Navigation Links
Neuronal conduction of excitation without action potentials based on ceramide production
Date:9/11/2007

Researchers from the Laboratoire de Physiologie Neurovg tative (CNRS-INRA-Universit Paul C zanne), the Laboratoire de Chimie Biologique Applique (INRA-Universit Paul Czanne) and from the D partement Lipoprotines et M diateurs Lipidiques (INSERM, Hopital Purpan Toulouse), and in particular Professor Jean-Pierre Miolan, Dr Jean-Pierre Niel, Directeur de Recherche CNRS, Dr Franois Terc , Charg de Recherche INSERM, Dr Abel Hiol Ma tre de confrence and Dr Caroline Fasano, author in 2004 of the PhD thesis Sphingolipides et physiologie des ganglions sympathiques pr vertbraux , have succeeded in demonstrating that a neuronal network in mammals can work perfectly with a mode of conduction of excitation that is independent of action potentials.

This new mechanism involves molecules known to play a role in numerous mechanisms of cell functioning, but not hitherto in conduction of excitation. To elucidate this mechanism, the teams have used a model of integrated physiology on an in vitro preparation in the mammal. This study has been performed using neuropharmacological and biochemical techniques.

This study, reporting the first discovery of conduction of excitation without action potentials, opens up new perspectives for research by breaking away from the classic concept of neuronal functioning. The neurons would thus be fitted with two modes of conduction of excitation, fast and slow, which might be used in different circumstances. This would have important consequences in the fields of physiological research and clinical practice.


'/>"/>
Contact: Lise Grandperrin
lise.grandperrin@univ-cezanne.fr
33-044-217-2791
Public Library of Science
Source:Eurekalert

Page: 1

Related biology news :

1. Neuronal traffic jam marks early Alzheimers disease
2. Molecular Partners Required For Appropriate Neuronal Gene Repression
3. Neuronal cell cultures kept on the straight and narrow
4. Taking the wrinkles out of motoneuronal disease
5. Cocaine high caused by interference in neuronal receiving stations
6. Widely used iron nanoparticles exhibit toxic effects on neuronal cells
7. Proteasome activator enhances survival of Huntingtons disease neuronal model cells
8. Striking the right balance between excitation and inhibition
9. UCSD researchers maintain stem cells without contaminated animal feeder layers
10. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
11. Two chemicals boost immune cells ability to fight HIV without gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... platform specifically designed for life science researchers to analyze and interpret datasets, ... Franklin, who made a major contribution to the discovery of the double-helix ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
Breaking Biology Technology: